IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 32 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $834,000 | -22.1% | 818,000 | -18.2% | 0.01% | -55.0% |
| Q2 2019 | $1,071,000 | -79.6% | 1,000,000 | -78.9% | 0.02% | -80.0% |
| Q1 2019 | $5,247,000 | -51.0% | 4,750,000 | -42.2% | 0.10% | -30.6% |
| Q3 2018 | $10,706,000 | -19.6% | 8,215,000 | -17.8% | 0.14% | -22.6% |
| Q2 2018 | $13,311,000 | +37.8% | 10,000,000 | +20.3% | 0.19% | +23.2% |
| Q4 2017 | $9,660,000 | +38.1% | 8,310,000 | +41.2% | 0.15% | +45.2% |
| Q3 2017 | $6,997,000 | -73.7% | 5,884,000 | -70.0% | 0.10% | -76.1% |
| Q2 2017 | $26,612,000 | -31.3% | 19,584,000 | -36.7% | 0.44% | -22.7% |
| Q1 2017 | $38,714,000 | +0.1% | 30,958,000 | -8.0% | 0.56% | -1.9% |
| Q4 2016 | $38,671,000 | -26.0% | 33,658,000 | -22.9% | 0.57% | -15.3% |
| Q3 2016 | $52,238,000 | +7.5% | 43,658,000 | -7.0% | 0.68% | -22.4% |
| Q2 2016 | $48,577,000 | – | 46,958,000 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,000,000 | $1,164,000 | 0.58% |
| CSS LLC/IL | 7,044,000 | $8,236,000 | 0.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $39,039,000 | 0.45% |
| DeepCurrents Investment Group LLC | 5,056,000 | $5,872,000 | 0.26% |
| SSI INVESTMENT MANAGEMENT LLC | 3,175,000 | $3,696,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,850,000 | 0.17% |
| LINDEN ADVISORS LP | 10,269,000 | $12,015,000 | 0.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $2,126,000 | 0.11% |
| HBK INVESTMENTS L P | 10,116,000 | $11,822,000 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 16,000,000 | $18,783,000 | 0.03% |